Pages with the fewest revisions

Showing below up to 50 results in range #1 to #50.

1. Sero-prevalence of Nipah antibodies among close contacts of the index case during 2019 Ernakulam outbreak (1 revision)
2. Nipah virus: pathogenesis, genome, diagnosis, and treatment (1 revision)
3. Clinical Medicine 2022 Vol 22, No 4: 348–52 - Review of Nipah virus encephalitis (1 revision)
4. Nipah virus: a re-emerging public health concern (1 revision)
5. A large-scale behavior change intervention to prevent Nipah transmission in Bangladesh: components and costs (1 revision)
6. Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials (1 revision)
7. High Pathogenicity of Nipah Virus from Pteropus lylei Fruit Bats, Cambodia (1 revision)
8. The deadly drink: Nipah virus transmission through date palm sap, cultural practices and the evolution of behavioral interventions in Bangladesh over two decades (1 revision)
9. Streamlined detection of Nipah virus antibodies using a split NanoLuc biosensor (1 revision)
10. Structural Studies of Henipavirus Glycoproteins (1 revision)
11. Assessing the risk of Nipah virus establishment in Australian flying-foxes (1 revision)
12. Beyond neurology: unravelling Nipah virus’s cardiovascular conundrum—an editorial (1 revision)
13. Encephalitis-predominant Nipah virus outbreaks in Kerala, India during 2024 (1 revision)
14. Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics (1 revision)
15. Metagenomic Snapshots of Viral Components in Guinean Bats (1 revision)
16. Nipah Virus Transmission from Bats to Humans Associated with Drinking Traditional Liquor Made from Date Palm Sap, Bangladesh, 2011–2014 (1 revision)
17. Nipah Virus Exposure in Domestic and Peridomestic Animals Living in Human Outbreak Sites, Bangladesh, 2013–2015 (1 revision)
18. Tackling a global epidemic threat: Nipah surveillance in Bangladesh, 2006–2021 (1 revision)
19. Nipah Virus: A Zoonotic Threat Re-Emerging in the Wake of Global Public Health Challenges (1 revision)
20. Improving clinical care of patients in Nipah outbreaks: moving beyond ‘compassionate use’ (1 revision)
21. Community willingness to participate in a Nipah vaccine trial in Bangladesh (1 revision)
22. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis (1 revision)
23. Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response (1 revision)
24. Addressing the recurrent Nipah Virus outbreaks: A call for vigilance, collaboration, and preparedness (1 revision)
25. Cat–wildlife interactions and zoonotic disease risk: a call for more and better community science data (1 revision)
26. Structural and functional analysis of the Nipah virus polymerase complex (1 revision)
27. Navigating Nipah virus: Insights, challenges, and recommendations (1 revision)
28. Bats and viruses: a death-defying friendship (1 revision)
29. Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature (1 revision)
30. Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018 (1 revision)
31. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge (1 revision)
32. Genomic characterization, transcriptome analysis, and pathogenicity of the Nipah virus (Indian isolate) (1 revision)
33. Predictors of mortality among critically ill SARS-CoV-2 infected patients—a retrospective cohort study, Kerala, India (1 revision)
34. Emerging threat: Nipah virus - A call for global preparedness and vigilance (1 revision)
35. Understanding and addressing the global impact: A systematic review and cross-sectional bibliometric analysis of Langya henipavirus and preexisting severe henipaviruses (1 revision)
36. Bot Test Page (1 revision)
37. Nipah Virus Infection Generates Ordered Structures in Cellulo (1 revision)
38. Nipah Virus: A Multidimensional Update (1 revision)
39. Combatting emerging infectious diseases from Nipah to COVID-19 in Kerala, India (1 revision)
40. A comparative genomic approach to decipher the mutations associated with Nipah viral human isolates from southeast Asia (1 revision)
41. Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease (1 revision)
42. Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters (1 revision)
43. Risk of Nipah Virus Seroprevalence in Healthcare Workers: A Systematic Review with Meta-Analysis (1 revision)
44. First Genomic Evidence of a Henipa-like Virus in Brazil (1 revision)
45. Nipah Virus Inhibitor Knowledgebase (NVIK): a combined evidence approach to prioritise small molecule inhibitors (1 revision)
46. A systematic review on Nipah virus: global molecular epidemiology and medical countermeasures development (1 revision)
47. Prophylactic protection from lethal henipavirus disease mediated by Nipah-derived defective interfering particles is influenced by challenge virus strain and viral species (1 revision)
48. Human Exposure to Bats, Rodents and Monkeys in Bangladesh (1 revision)
49. Jme-2023-109469 (1 revision)
50. Ephrin-B2 and ephrin-B3 as functional henipavirus receptors (1 revision)